MedPath

Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors

Not Applicable
Not yet recruiting
Conditions
Stroke
Aphasia Following Cerebral Infarction
Hemiparesis After Stroke
Registration Number
NCT07000019
Lead Sponsor
New York Medical College
Brief Summary

The goal of this clinical trial is to learn if a program that combines language and arm treatment can improve language and movement problems in people with chronic stroke. The mains questions it aims to answer are:

* To determine the extent to which this combined treatment can improve language.

* To determine the extent to which the combined treatment can improve arm movements.

Researchers will compare the effects of this combined treatment with treatment that targets arm movements alone.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
28
Inclusion Criteria
  1. Male or female patients between 18-90 years of age.
  2. Right-handed prior to stroke
  3. English-speaking (monolingual)
  4. History of single left-hemisphere stroke at least 6 months prior to enrollment
  5. Presence of aphasia and naming deficits on Western Aphasia Battery (WAB-R)
  6. Comprehension score above 4 on WAB-R
  7. Unilateral upper limb paresis (Fugl-Meyer Upper Extremity score <56)
  8. Documentation of signed Informed Consent by the study participant.
Exclusion Criteria
  1. Diagnosis or history of speech impairment prior to stroke
  2. Severely limited speech output (score below 2 on spontaneous speech portion of WAB-R)
  3. Inability to perform screening tasks due to severe language and/or cognitive impairment
  4. Condition limiting passive movement in the range of motion required for robotic therapy (e.g. fixed contracture)
  5. Any medical or psychiatric condition that may impact participation or compliance with study procedures or activities in the opinion of the investigator

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Philadelphia Naming TestBaseline to 1 week post-treatment
Fugl-Meyer Upper Extremity Motor AssessmentBaseline to 1 week post-treatment
Secondary Outcome Measures
NameTimeMethod
Box and Blocks TestBaseline to 1 and 4 weeks post-training
Apraxia Battery for AdultsBaseline to 1 and 4 weeks post-training
Western Aphasia Battery-Revised Aphasia QuotientBaseline to 4 weeks post-treatment
Stroke and Aphasia Quality of Life Scale-39Baseline to 1 and 4 weeks post-training
Apraxia of Speech Rating ScaleBaseline to 1 and 4 weeks post-training

Trial Locations

Locations (1)

Westchester Medical Center / New York Medical College

🇺🇸

Valhalla, New York, United States

Westchester Medical Center / New York Medical College
🇺🇸Valhalla, New York, United States
Cristina Falo, PhD
Contact
cristina.falo@wmchealth.org
Tomoko Kitago, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.